Assessing liver fibrosis without biopsy in patients with HCV or NAFLD
- PMID: 30849036
- DOI: 10.3949/ccjm.86a.17118
Assessing liver fibrosis without biopsy in patients with HCV or NAFLD
Abstract
Staging of liver fibrosis is increasingly done using noninvasive methods, in some cases obviating the need for liver biopsy. Scores based on laboratory values and demographic variables have been developed and validated for assessing fibrosis in patients with hepatitis C virus (HCV) infection and nonalcoholic fatty liver disease (NAFLD), as have several imaging methods that measure shear-wave velocity, a reflection of fibrosis severity.
Copyright © 2019 Cleveland Clinic.
Comment in
- 
  
  The tests that we order define us.Cleve Clin J Med. 2019 Mar;86(3):150. doi: 10.3949/ccjm.86b.03019. Cleve Clin J Med. 2019. PMID: 30849031 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
- Medical
 
        